ACT's Dr. Robert Lanza to Receive the Il Leone di San Marco Award in Medicine

Sep 26, 2013 1675

Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that the company's Chief Scientific Officer, Robert Lanza, MD, has been nominated to receive the prestigious Il Leone di San Marco award in Medicine.

For thirty-three years, the Italian Heritage and Culture Committee of the Bronx and Westchester has acknowledged outstanding Americans in fields such as the Performing Arts, Entertainment, Medicine, Journalism, Literature, Playwriting, Government, Science, Academia or Business. Past honorees have included Stanley Tucci, Paul Giamatti, Paul Sorvino, Danny Aiello, Armand Assante, Tony Danza, Susan Lucci, Dion DiMucci, Phil Ramone, Bart Giamatti, and Rudy Giuliani.

Read more

Source: http://www.dailyfinance.com

You may be interested